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ABSTRACT                        Biological barriers are indispensable for the integrity and function of many ver-
tebrate organs. The barrier function is based on intercellular protein complexes of the plasma 
membrane which form paracellular diffusion barriers and separate internal and external fluid 
compartments, an indispensable prerequisite for every organ development and function. The 
review summarizes key characteristics and molecular structure of intercellular junctions (tight 
junctions and adherens junctions) responsible for cellular barrier formation. One of the most 
important such cellular barriers is the blood-brain barrier (BBB) which forms an active interface 
between the circulation and neural tissue. Its principal cellular components are cerebral en-
dothelial cells, pericytes and astrocytes, whose finely tuned interactions are needed for a proper 
function. The review highlights the most important functions of the BBB including some novel 
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introduction
Parallel with the appearance of multicellular organisms, 
distribution of biological functions among different cells 
groups became a necessity. This distribution of functions 
– besides an increased evolutionary effectiveness – led to 
compartmentalization which became of vital importance for 
the proper function of higher multicellular organisms. The 
barrier between compartments is formed by specialized cell 
types. External surfaces of the body are covered by epithelial 
cells, while most internal surfaces are lined by endothelial 
cells, in the case of the blood-brain barrier these are special-
ised cerebral endothelial cells (CECs). These barriers control 
paracellular diffusion and are mainly formed by intercellular 
protein complexes of the plasma membrane. The most im-
portant structures sealing the paracellular route of transport 
(between the cells) are tight junctions (TJs), which are protein 
complexes joining together the membranes of adjacent cells. 
The backbone of the TJs is formed by claudin proteins.
The integrity and function of many vertebrate organs de-
pend on these barriers, which separate internal and external 
fluid compartments, which is an indispensable prerequisite 
for the development and function of every organ.
Most important organs with tight biological 
barriers
Skin
The epidermis is the outermost layer of the skin with direct 
contact to the environment and thus plays an important role 
in the protection of the organism. The epidermis is formed 
by several keratinocyte layers with different characteristics, 
organized in a multilayered, stratified epithelium. Tight 
junctions connect keratinocytes, and TJ proteins exhibit dif-
ferential expression in different epidermal layers. Besides 
playing a pivotal role in barrier formation, TJ proteins of the 
skin may be involved in regulation of cell proliferation and 
differentiation and determination of tissue polarity. Several 
diseases including psoriasis vulgaris and atopic dermatitis are 
associated with alterations in TJ protein expression (Kirschner 
et al. 2012).
Kidney
In kidney the barrier is located along the renal tubule and sep-
arates urine from renal parenchyma. Different segments of the 
nephron have different paracellular transport characteristics, 
which is reflected by the distribution of junctional proteins 
in renal tubule epithelial cells as well. For example the pore-
forming claudin-2 is expressed preferentially in the proximal 
tubule which has higher paracellular permeability, whereas 
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claudin-1 is more abundant in distal collecting segments (Kirk 
et al. 2010). Aberrant expression of claudin proteins could be 
implicated in a series of renal diseases (Balkovetz 2006) and 
could lead to abnormalities of reabsorption.
Intestine
The intestinal barrier, located at the level of epithelial cells 
covering the lumen of the intestine, separates the content of 
the intestine from the rest of the body. The integrity of the 
barrier is crucial not only for the absorption of nutrients but 
for host defence against pathogens and ingested toxic sub-
stances as well. Expression of junctional proteins in intestinal 
epithelial cells is under the control of a complex regulatory 
machinery. Expression of TJ proteins is altered not only in 
a large variety of intestinal diseases but also in colorectal 
cancer (Lu et al. 2013).
Liver
In the liver the barrier is localized along the bile canaliculi 
forming the blood-biliary barrier and bile ducts. This is re-
flected by the localization of TJ proteins as well, which are 
mainly expressed in the apical region of hepatocytes forming 
bile canaliculi and bile duct epithelial cells (cholangiocytes). 
The liver is very abundant in TJ proteins which play piv-
otal role in the regulation of paracellular permeability, bile 
secretion, and cell polarity. Beside this, TJ molecules may 
be involved in mediating Hepatitis C virus infection and it 
has been suggested that liver cancer is also associated with 
changed TJ protein expression (Lee and Luk 2010).
Lung
In the lung an active barrier is located at the interface of 
blood and airspace. The principal cellular elements of this 
barrier are lung epithelial cells which express at least 14 
different types of claudins, of which claudin-3, claudin-4, 
and claudin-18 are the most prominent. Deterioration of the 
barrier function, due to altered TJ protein expression associ-
ated with several diseases, can lead to pulmonary oedema 
formation (Koval 2013).
Further organs in which functional biological barriers 
play an important role include the testis and the brain. In the 
testis the barrier is located between adjacent Sertoli cells of 
the seminiferous tubule, forming the blood-testis barrier. The 
central nervous system (CNS) is protected from the external 
environment by the blood-brain barrier (BBB) located to en-
dothelial cells of cerebral capillaries and the blood-CSF bar-
rier located to the epithelial cells of the choroid plexus. The 
blood-brain barrier will be discussed in more detail below. 
Molecular basis of the cellular barrier formation
Barrier forming cells are interconnected by multiple types 
of intercellular junctions including TJs, adherens junctions 
(AJs), desmosomes and gap junctions. However, in the bar-
rier formation TJs and AJs play by far the most important 
role (Fig. 1).
Tight junctions 
Tight junctions are cellular structures located to the region 
where two cells virtually join their membranes together form-
ing an impermeable barrier between the cells. TJs are com-
posed of a branching network of TJ strands whose complexity 
is in direct relation with the impermeability of the barrier. 
TJs have a double function. By sealing the intercellular cleft 
they restrict the free movement of different solutes between 
the adjacent cells (barrier function). In addition, by restrict-
ing the free movement of membrane proteins TJs separate 
the apical membrane from the basolateral membrane, thus 
contributing substantially to the development of cell polarity 
(fence function).
Tight junction proteins
Most of our knowledge regarding tight junction structure and 
function originates from studies performed in epithelial cells. 
Although there are some differences between endothelial and 
epithelial cells in this respect, the assembly principles remain 
Figure 1. Molecular structure of the interendothelial junctions. 
Schematic representation of interendothelial junctional complexes 
presenting the transmembrane and cytoplasmic plaque components 
of the TJ and AJ.
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similar. Proteins of the TJs fall into two categories: transmem-
brane proteins and cytoplasmic plaque proteins.
Transmembrane proteins of tight junctions
Although tight junctions have been described earlier, identi-
fication of the sealing elements of the junctional cleft started 
with the discovery of the first transmembrane protein of the 
tight junction by Furuse et al., which was occludin (Furuse 
et al. 1993). Since then the number of identified TJ trans-
membrane proteins increased rapidly and two main classes 
can be identified.
Tetraspan proteins
Tetraspan proteins, characterized by four transmembrane do-
mains include claudins and the Marvel family of proteins.
After the initial discovery of claudin-1 and -2 (Furuse et 
al. 1998) now we know at least 27 members of the claudin 
family (Mineta et al. 2011). Claudins are relatively small 
proteins (20-27 kDa) and constitute the backbone of the tight 
junctions. In CECs claudin-5 is by far the most abundant fam-
ily member, but claudin-1, -3 and -12 are also present in rel-
evant amounts. The importance of claudin-5 is demonstrated 
by knock-out animals: claudin-5 loss opens the BBB for 
molecules smaller than 800 Da (Nitta et al. 2003). Depending 
on the composition of the extracellular loops, claudins have 
distinct functions: some of them are tightening the paracel-
lular barrier, while others are pore-forming. Claudins are 
capable of both homo- and heterophylic interactions and can 
bind other claudins in trans interactions between cells and in 
cis within the membrane of the same cell (Krause et al. 2008; 
Van Itallie 2013).
The Marvel family of transmembrane TJ proteins con-
sists of occludin, tricellulin (Marvel D2) and Marvel D3. 
The membrane topology of occludin – which has several 
alternative splice variants – is very similar to that of claudins; 
however, they do not show sequence homology, and occludin 
is significantly larger compared to claudins (60-65 kDa). 
Interestingly, occludin is not indispensable for TJ formation 
as revealed by studies performed on occludin-deficient mice 
(Saitou et al. 2000). Instead occludin may have a regulatory 
and accessory function in TJ formation and physiology. Oc-
cludin can be regulated by posttranslational modifications, 
especially phosphorylation on serine, threonine (Cordenonsi 
et al. 1999) or tyrosine (Tsukamoto and Nigam 1999; Chen 
at al. 2002) residues; can be internalized and is subject prote-
olytic degradation (by metalloproteinases or the proteasome) 
(Traweger et al. 2002).
Tricellulin was first described in epithelial cells as a 
protein localized to tricellular contacts. Later tricellulin has 
been detected in bicellular contacts and recently it has been 
detected in cerebral endothelial cells as well (Mariano et al. 
2013).
MarvelD3 has also been shown to be expressed in both 
epithelial and endothelial cells (Steed et al. 2009), and it was 
suggested that occludin, tricellulin and MarvelD3 have over-
lapping but non-redundant functions (Raleigh et al. 2010).
Single span proteins
Single span TJ molecules belong either to the immuno-
globulin-like superfamily or are non-immunoglobulin-like 
single span proteins. The most prominent members of the 
immunoglobulin-like superfamily single span molecules are 
the junctional adhesion molecules (JAMs) characterized by 
two extracellular loops and a single transmembrane domain. 
JAMs typically form homotypic cell-cell contacts between en-
dothelial or epithelial cells. Endothelial cells express JAM-A, 
JAM-B and JAM-C and they play a role in the transend-
othelial migration of leukocytes (Jia et al. 2013). Further 
Ig-superfamily protein members shown to be localized to TJs 
include CAR (coxsackie- and adenovirus receptor) (Cohen et 
al. 2001), CLMP (coxsackie - and adenovirus receptor-like 
membrane protein) (Raschpberger et al. 2004), JAM-4 (Hi-
rabayashi et al. 2003), and ESAM (endothelial cell-selective 
adhesion molecule) (Hirata et al. 2001); however, their role 
in the formation of the BBB is largely unknown. More re-
cently three new Ig-like proteins, the angulins were found 
to be localized into the tricellular junctions and are required 
for the assembly of this structure (Higashi et al. 2013). The 
present knowledge about the role of non-immunoglobulin-
like single span molecules like CRB3 or BVES/Pop1 (blood 
vessel/epicardial substance) in the formation or maintenance 
of the BBB is scarce. CRB3 regulates epithelial development 
(Whiteman et al. 2014) and BVES/Pop1 co-localizes with 
ZO-1 and occludin in polarized epithelial cells. 
Plaque proteins of the TJs
The connection between transmembrane proteins of tight 
junctions and the cellular cytoskeleton is mediated by periph-
eral (cytoplasmic or plaque) tight junction proteins. These 
include proteins containing PDZ domains, of which MAGUK 
(membrane-associated guanylate kinase) proteins are the 
best characterized so far. The most prominent subgroup is 
represented by the zonula occludens (ZO) proteins having a 
modular nature consisting of PDZ domains, an SH3 domain, 
followed by a catalytically inactive guanylate kinase (GUK) 
domain. ZO-1 and ZO-2 are present in both epithelial and 
endothelial cells, whereas the expression of ZO-3 seems to 
be restricted to epithelial cells. Non-PDZ proteins localized 
to the TJ are cingulin and JACOP (junction-associated coiled-
coil protein)/paracingulin; their role in the function of BBB 
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has not been characterized. Importantly, some of the periph-
eral TJ proteins serve not only as molecular scaffolds, but can 
function as cellular signalling molecules as well (Farkas et al. 
2012; Traweger et al. 2013). In recent years a considerable 
number of other junctional proteins have been described, 
but their role still needs to be clarified. In addition, several 
other regulatory proteins have been demonstrated to localize 
to the TJ-plaque, these include protein kinases (Chen et al. 
2002), heterotrimeric G-proteins (Saha et al. 1998) cyclin D1 
(Capaldo at al. 2011) and Rho family GTPases (Quiros and 
Nusrat 2014). These findings indicate that the TJ is a dynamic 
structure able to respond to environmental stimuli and is 
regulated by a sophisticated signalling network responsible 
for the fine tuning of paracellular permeability.
Adherens junctions
Adherens junctions are present in many cell types and are 
located just below the TJ complex. The intimate connection 
to the TJs is indicated by the existence of common structural 
elements, like ZO-2 (Itoh et al. 1999). The transmembrane 
proteins of the AJs are the classical cadherins (N, -E, -VE, 
-P cadherins) which are single span transmembrane proteins 
capable of homophylic Ca2+-dependent binding. The most 
prominent cadherin of cerebral endothelial cells is VE-cad-
herin, but the presence of N-cadherin has been documented 
as well (Dejana and Orsenigo 2013). Cadherins are linked 
to the actin cytoskeleton through catenins (α-, β-, γ- and 
p120-catenin), of which β- and γ-catenin can bind directly 
to cadherins. In addition, β-catenin participates directly in 
signal transduction as well.
Another major protein complex of adherens junctions 
consists of nectins linked to afadin/AF6. PECAM-1 also 
participates in the formation of endothelial adherens junc-
tions. Adherens junctions are very important not only in cell 
adhesion, but in cell migration and thus metastasis formation 
as well.
Phosphorylation of junctional proteins
Practically all components of the TJ and AJ are phosphopro-
teins and their phosphorylation status is crucial for regulat-
ing intercellular junction structure and function, and thus 
barrier properties. Occludin is phosphorylated by PKCζ 
and PKCη on specific C terminal threonines promoting TJ 
assembly (Jain et al. 2011), while S408 phosphorylation by 
casein kinase 2 (CK2) reduces the association of occludin 
with other TJ components (Suzuki et al. 2009; Raleigh et 
al. 2011). Interestingly, S490 phosphorylation of occludin 
is required for centrosome separation and mitosis (Runkle 
et al. 2011). The phosphorylation state of tricellulin also ap-
pears to closely associate with TJ function (Takasawa et al. 
2013). Several members of the claudin protein family also 
can be phosphorylated. For example the phosphorylation of 
claudin-2 on S208 at the C terminus of the protein promotes 
its membrane retention. The cAMP-dependent PKA-mediated 
dephosphorylation of the same residue targets claudin-2 to 
lysosomes (Van Itallie et al. 2012). On the contrary, the cor-
responding serine of claudin-16 (S217) is phosphorylated in a 
cAMP/PKA-dependent manner (Ikari et al. 2008). Claudin-3 
is also directly phosphorylated by PKA at T192 and this de-
creases its incorporation into TJs (D’Souza et al. 2005). On 
the other hand claudin-5 is increased at cell-cell junctions 
when it is phosphorylated in response to cAMP (Ishizaki 
et al. 2003). Phosphorylation of claudin-1 and -4 by aPKC 
is again necessary for TJ formation (Aono and Hirai 2008; 
Banan et al. 2005). aPKC can also directly phosphorylate the 
single span immunoglobulin like TJ protein JAM-A at S285 
and promotes TJ maturation (Iden et al. 2012), while CAR is 
phosphorylated by PKCδ and this modification is important 
for TJ stability (Morton et al. 2013). The recently discovered 
single pass transmembrane protein of the tricellular TJ, LSR 
requires phosphorylation by JNK1/2 for proper localization 
to tricellular junctions (Nakatsu et al. 2014).
We used phenylarsine oxide (PAO) an inhibitor of protein-
tyrosine phosphatases (PTPs) to study the effect of tyrosine 
phosphorylation on the blood-brain barrier. As shown in Fig. 
2A, inhibition of PTPs induces a drop of transendothelial 
electric resistance (TEER) as early as 20 minutes after the 
start of treatment. Furthermore, we analysed the distribution 
of selected junctional proteins in Triton x-100 soluble and 
insoluble fractions to detect shifts in the more membrane 
associated and more cytoskeleton associated protein pools 
in response to PAO treatment. As presented in Fig. 2B, oc-
cludin and ZO-1 levels increase in the Triton X-100 soluble 
fraction in response to 1 hour 30 µM PAO treatment, while the 
same proteins exhibit a drastic decrease in the Triton X-100 
insoluble pool. Inversely, PAO treatment results in a drop of 
ZO-2 and β-catenin levels in the soluble pool while both are 
greatly increased in the insoluble pool.
Thus it is clear that differential phosphorylations of 
junctional components are principal regulators of barrier 
homeostasis.
The blood-brain barrier (BBB)
The BBB is an active interface with an estimated surface 
of about 10-20 m2, which separates the systemic circulation 
from the CNS, and strictly controls the molecular and cellular 
traffic between the blood and the brain. Its proper function is 
indispensable for the maintenance of a steady-state environ-
ment needed for neuronal function.
It was Paul Ehrlich who in 1885 (Ehrlich 1885) observed 
that some dyes injected intravenously stained strongly vari-
ous organs, but the brain remained largely unstained. This 
observation led to investigations (Lewandowski 1900; Gold-
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mann 1913) to identify what blocks the entry of hydrophilic 
molecules from the blood to the brain. The term blood-brain 
barrier was created by Stern and Rothlin (1918) nearly 100 
years ago. Using electron microscopy and molecular tracers, 
Reese and Karnowski (1967) clearly demonstrated that the 
barrier is located at the level of cerebral endothelial cells. In 
1987 Janzer and Raff described the essential modulatory role 
of astrocytes and the 1990s witnessed the era of molecular 
dissection of the tight junctions, the cellular structure crucial 
for the formation of the paracellular barrier.
Acknowledging the special role of the cerebral endothe-
lium, the importance of other cellular components like 
astrocytes and pericytes in the formation of the BBB has 
become increasingly evident, which led to the formation of 
the concept of “neurovascular unit” (Neuwelt 2004).
Cellular composition of the BBB
The principal cellular components of the BBB are cerebral 
endothelial cells (CECs), pericytes and astrocytes (Fig. 3). 
Microglia and nerve endings as may have regulatory roles 
as well.
Endothelial cells
Cerebral endothelial cells are elongated cells of mesodermal 
origin lining the inside of cerebral capillaries. They consti-
tute around 0.1-1% of the brain volume; however, they are 
involved in the pathogenesis of a significant number of CNS 
diseases. CECs have the common characteristics of endothe-
lial cells, including expression of factor VIII-related antigen, 
high alkaline phosphatase and γ-glutamyl transpeptidase 
activity, specific lectin binding (Bandeira simplicifolia lectin 
B4) and uptake of acetylated-LDL. In addition, these cells 
have characteristics specific to epithelial cells as well, which 
confer them the barrier characteristics: presence of continu-
ous strands of tight junctions sealing the intercellular cleft 
between adjacent CECs, very low pinocytotic and transcytotic 
Figure 2. Inhibition of tyrosine phosphatases affects junctional protein distribution. Cells were treated with protein tyrosine phosphatase inhibi-
tor phelylarsine oxide (PAO) at 30 µM. A TEER decreased by over 50% within two hours. B Marked tyrosine phosphorylation was observed over 
a wide molecular weight range in the Triton X-100 insoluble fraction of cell lysates by Western blot. The increased tyrosine phosphorylation 
resulted in a redistribution of junctional proteins between the Triton X-100 soluble and insoluble fractions.
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activity, presence of specific enzymes, low level of adhe-
sion molecules, expression of specific transporter systems 
and presence of a high number of mitochondria suggesting 
a high energy requirement of these cells. Besides common 
characteristics, cerebral endothelial cells show a remarkable 
heterogeneity (Krizbai et al. 2000) and responsiveness to ex-
tracellular stimuli modulated by a sophisticated intracellular 
signalling network (Fabian et al. 1998; Wilhelm et al. 2007; 
Hutamekalin et al. 2008).
Astrocytes
Astrocytes are cells of neuroectodermal origin with a large 
variety of morphology depending on their location and 
activation state. They do not play significant role in in the 
formation of the physical barrier; however, their bidirectional 
interaction with CECs is important in the maintenance of 
the functional integrity of the BBB. Astrocytes contact the 
capillaries by specialized structures called endfeet, which 
nearly completely ensheath endothelial cells and pericytes of 
the capillaries. In post-capillary venules the contact is not so 
intimate, which allows the formation of a perivascular space, 
and in arterioles a smooth muscle layer separates endothelial 
cells from astrocytes (Abbott et al. 2006). Astrocytic endfeet 
are rich in mitochondria, caveolae, coated pits and vesicles, 
indicating an active material exchange and high energy de-
mand. Astrocyte endfeet express high levels of aquaporin-4 
(forming the OAPs – orthogonal array of intramembraneous 
particles), connexin-43, the purinoreceptor P2Y4 and the Kir 
4.1 K+ channel.
Molecular mechanisms of the interaction between as-
trocytes and endothelial cells are complex (Fig. 4), and our 
knowledge in this respect is far from being complete. Besides 
a physical contact, astrocytes synthesize biologically active 
molecules which modulate the BBB phenotype. Such fac-
tors are transforming growth factor-β (TGF-β), glial-derived 
neurotrophic factor (GDNF), basic fibroblast growth fac-
tor (bFGF), IL-6 (Haseloff et al. 2005) or Sonic hedgehog 
(Alvarez et al. 2011). Recent proteomic analysis revealed 
changes in 55 proteins in CECs in response to astrocytes, 
Figure 3. Cellular structure of the neurovascular unit. Graphic repre-
sentation of the neurovascular unit showing the spatial relations of 
its cellular components. Microcapillaries are lined by endothelial cells 
which in turn are sheathed in the basement membrane. Pericytes are 
closely associated with the endothelial cells as they reside within the 
basement membrane. The endfeet of astrocytes cover close to the 
entire outer surface of the capillary leaving only small patches for 
association with neural processes.
Figure 4. Cerebral endothelial cell-astrocyte interactions. Cartoon depicting the close association of astrocytes with endothelial cells. Even though 
the astrocytes are not physically part of the barrier, they are in intimate, bidirectional regulatory relation with endothelial cells.
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involved mainly in cell structure and motility and protein 
metabolism and modification (Pottiez et al. 2011). In addition, 
extracellular matrix produced by astrocytes can induce BBB 
characteristics in brain endothelial cells.
On the other hand, endothelial cells also influence as-
trocytes. As such, endothelial cells increase the number of 
OAPs in the astrocytic endfeet, can induce the expression of 
plasminogen activator inhibitor-1 mRNA in astrocytes and 
CECs-derived LIF has been shown to induce astrocytic dif-
ferentiation (Mi et al. 2001).
Pericytes
Pericytes were described in 1873 by the French scientist 
Charles-Marie Benjamin Rouget and were originally called 
Rouget cells. Later they were renamed to pericytes, due to 
their anatomical location abluminal to the endothelial cell 
and luminal to parenchymal cells. Pericytes are a very het-
erogeneous cell population, and the only characteristic which 
identifies them is their location. Several markers have been 
used for their identification, including smooth muscle actin, 
PDFGR-β, chondroitin sulfate proteoglycan 4 (CSPG4/NG2), 
desmin, but none of them is specific only to pericytes and is 
expressed in all pericytes.
Pericytes are localized in the duplication of the basement 
membrane covering approximately 22-32% of the endothelial 
surface. The ratio of pericytes to CECs varies from species to 
species: in the rat capillary is 1:5, in the mouse the ratio is 1:4 
and in humans 1:3-1:4. Pericytes function at the BBB in at 
least two ways: by regulating BBB-specific gene expression 
patterns in endothelial cells, and by inducing polarization of 
astrocyte endfeet surrounding CNS blood vessels. The inter-
action between pericytes and endothelial cells is very complex 
(Fig. 5). Endothelial cells secrete PDGF-β, which plays a 
crucial role in pericyte recruitment to capillaries. An impor-
tant molecule in endothelial cell-pericyte communication is 
TGF-β, secreted by both pericytes and CECs, and both cells 
express receptors for TGF-β. TGF-β is able to inhibit pericyte 
proliferation, but also enhances pericyte attachment to CECs 
mediated by the upregulation of N-cadherin. In endothelial 
cells, depending on which receptor type is activated, TGF-β 
can upregulate proliferation and migration of CECs or induce 
differentiation, inhibition of proliferation, and stabilization of 
the BBB. Ang-1 expressed by pericytes is necessary for vessel 
stability and maturation, a process mediated by Tie-2 recep-
tors. An important role in the communication between CECs 
and pericytes plays Notch signalling which is able to regulate 
pericyte attachment to endothelial cells via N-cadherin (Hill 
et al. 2014). In addition, it seems that the differentiation stage 
of pericytes determines their effect on the endothelium as well 
(Thanabalasundaram et al. 2011).
The importance of pericytes in the formation of the BBB 
is supported by the finding that loss of pericytes by targeting 
the PDGF-β signalling pathway, leads to endothelial hyper-
plasia, abnormal vasculogenesis (Hellstom et al. 2001) and 
an increased BBB permeability, which is mediated mainly by 
increased endothelial transcytosis (Armulik et al. 2011).
The basement membrane
The basement membrane covers endothelial cells and as-
trocyte endfeet and engulfs pericytes. All three cell types 
contribute to its formation. It is composed of collagen (es-
pecially collagen type IV), elastin, laminin, fibronectin and 
proteoglycans (heparan sulfate and glycosaminoglycans). 
In addition, adhesion and signalling molecules may also be 
present. Components of the basement membrane may regulate 
barrier properties of the endothelial layer (Hartmann et al. 
2007), and alterations in the basement membrane has been 
associated with increased BBB permeability observed under 
pathological conditions (Cardoso et al. 2010).
Role of the BBB
Due to its location between the neural tissue and systemic 
circulation, the blood-brain barrier regulates the transport of 
different molecules and cellular elements between the two 
compartments. These functions imply that the BBB has a con-
siderable contribution to the maintenance of the homeostasis 
of the CNS required for proper neural function. The BBB has 
a dual function, a barrier and a carrier one.
Barrier functions
The barrier function consists of restricting the transport of 
potentially toxic or harmful substances and cells from the 
Figure 5. Cerebral endothelial cell-pericyte interactions. The interaction 
between pericytes and endothelial cells depicted in this figure are very 
complex. For example endothelial cells regulate pericyte recruitment, 
and in turn pericytes are important for endothelial maturation. Both 
cell types affect the other with regards to proliferation, migration and 
attachment through N-cadherin via TGF-β and Notch signalling.
46
Krizbai et al.
blood to the brain. For this the BBB is equipped with a four-
fold defence line. The paracellular barrier has its cellular and 
molecular basis in the closely apposed cerebral endothelial 
cells interconnected by a continuous line of tight junctions, 
which makes passage between the cells practically impos-
sible. The transcellular barrier is provided by the low level 
of endocytosis and transcytosis, which characterizes cerebral 
endothelial cells under physiological conditions. The cerebral 
endothelium is equipped with a whole set of enzymes which 
form an enzymatic barrier. Endothelial enzymes which are 
capable of degrading biologically active substances entering 
the cells include acetylcholinesterase, alkaline phosphatase, 
γ-glutamyl transpeptidase and monoamine oxidases. The 
fourth defence line is provided by efflux transporters or ABC 
(ATP-binding cassette) transporters. These transporters use 
the energy of ATP to transport – against the concentration gra-
dient – a wide variety of lipophilic substrates which can freely 
pass cellular membranes. Unfortunately, important drugs 
and drug candidates are also substrates of these transporters, 
which therefore constitute a major impediment in the therapy 
of CNS diseases. The most abundant ABC transporters of the 
cerebral endothelium are ABCB1 (P-gp, MDR – multidrug 
resistance protein), members of the ABCC family (MRPs 
– multidrug resistance-related proteins) including ABCC1, 
ABCC4, ABCC5, and ABCG2 (BCRP – breast cancer related 
protein). It is important to note that ABCG2 plays a more im-
portant role than ABCB1 in human capillaries in comparison 
to rodent brain capillaries.
Carrier functions
Some of the important nutrients of the brain are hydrophilic 
molecules, like glucose and amino acids, which are not able 
to freely pass through cellular membranes. Additionally, 
hydrophilic waste products of cell metabolism need to be 
removed from the brain. Therefore, the cerebral endothelium 
is equipped with a whole set of transporters which enable 
nutrient transport to the brain and removal of metabolites. 
These transporters belong to the solute-like carrier group of 
membrane transporters (SLC), having more than 50 families 
and over 300 transporters. These use facilitated transport 
(which allow solutes to flow downhill their electrochemi-
cal gradients) or secondary active transport (flow of solutes 
against their electrochemical gradient coupled to transport of 
a second solute that flows downhill with its gradient).
One of the most important SLC transporter of the BBB 
is the glucose transporter SLC2A1 (GLUT1), a 12 trans-
membrane domain containing protein with Km 2-5 mM for 
glucose. Further transporters include: members of the SLC3 
and SLC7 family, transporting cationic and neutral amino 
acids (SLC7A5=LAT1, SLC7A6=LAT2, SLC7A3 system 
Bo+ – basic amino acid preferring); SLC15 (proton/oligo-
peptide transporters – PEPT1, 2); SLC16 (monocarboxylate 
transporters – MCT: lactate, pyruvate, hydroxybutyrate); 
SLC21(organic anion transporters – OATPs); SLC22 (organic 
anion, zwitterion, cation transporters) and SLC38 (sodium-
coupled neutral amino acid transporters, including system 
A, alanine preferring SLC38A2, and system N, glutamine 
preferring SLC38A5).
In addition to these, cerebral endothelial cells are equipped 
with special transporters which transport biologically active 
molecules, like neurotransmitters. Glutamate transporters 
EAAT1 (SLC1A3) and EAAT2 (SLC1A2) have a special im-
portance as they may participate in the removal of glutamate 
excess accumulated in response to brain ischemia. Besides 
this, it has been demonstrated that the cerebral endothelium 
Figure 6. Transport pathways through the BBB. Schematic representations of transport routes though the BBB. The two main groups are paracel-
lular and transcellular transport. The paracellular transport is regulated by the protein composition of the TJ. Transcellular transport can occur 
via diffusion in case of lipid soluble molecules or can be mediated by transporter proteins, receptors or adsorption.
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is able to transport serotonin (SLC6A4) (Brust et al. 2000) 
and histamine as well (SLC22A3). Since the tight junction 
is largely impermeable to ions under physiological condi-
tions, transfer of ions is mediated by different ion transport-
ers. These include Na+/K+ ATP-ase, Na+/K+/2Cl- transporter 
(SLC12A), Na+/H+ antiporter, H+ ATP-ase and saturable 
Cl- transporter. Principal transport routes across the BBB are 
shown in Figure. 6.
Receptors on cerebral endothelial cells
In order to adequately respond to environmental stimuli, 
CECs are equipped with a whole set of membrane receptors. 
These include adrenergic receptors, receptors for histamine 
(H1, H2), bradykinin, endothelin, opiate, glutamate, sero-
tonin and adenosine. Furthermore, receptors involved in 
receptor mediated endocytosis are also expressed. The most 
important are: insulin receptor, transferrin receptor and LDL 
receptor. These receptors can be targeted for drug delivery 
to the brain.
Clinical aspects of the BBB
By controlling the traffic between the neural tissue and the 
systemic circulation, the BBB plays an important role in a 
large number of neurological disorders. Dysfunction of the 
BBB may be either a causative factor, or may be associated 
with a disease significantly affecting its outcome. The most 
significant BBB dysfunction associated with diseases is the 
increase in permeability, allowing potentially toxic substances 
to enter the brain and aggravate the damage. Pathological con-
ditions with increased BBB permeability include stroke, brain 
trauma epilepsy, neurodegenerative disorders (Alzheimer’s 
disease, ALS, Parkinson’s disease), brain tumours (primary 
tumours and metastases), inflammatory disorders and CNS 
infections. The mechanisms of permeability change include 
increased paracellular permeability, increased pinocytosis, 
changes in endothelial cell surface charge or cytoskeletal 
changes. A special case of increased permeability is the 
increased cellular transmigration (immune cells, metastatic 
cells), which – under physiological conditions – is very 
restricted. Cellular transmigration can occur paracellularly 
or transcellularly as well (Carman and Springer 2004). The 
transmigration process starts with rolling of the cells and 
loose attachment to the endothelium, mediated by selectins, 
followed by firm adhesion, in which integrins play a crucial 
role. These steps are followed by the transmigration step 
(Engelhardt 2008).
The relative impermeability of the BBB may also cause 
severe clinical consequences, because the BBB constitutes 
the largest impediment for large or hydrophilic drugs to 
reach therapeutically relevant concentration in the brain. A 
low brain penetration has been observed for drugs which are 
substrates of efflux transporters as well. Therefore, one of 
the major challenges of drug industry is how to circumvent 
or breach the BBB specifically in order to target drugs to the 
brain.
Summary and conclusions
The principal cell types involved in barrier formation are 
epithelial and endothelial cells. Epithelial barriers interface 
the body and the external environment, such as in kidney, 
intestine, liver, lung, skin, brain choroid plexus; the main 
barrier based on endothelial cells is the BBB. The structural 
basis of paracellular barriers is formed by large protein com-
plexes. Some constituent proteins have clearly characterised 
roles defining the structure and properties of the barrier, 
like the claudins. Other ostensibly structural proteins have 
been found to play crucial roles in modulating the barriers 
or even regulate gene expression and mitosis such as zonula 
occludens proteins and occludin. Regardless of their roles, all 
constituents of intercellular junctions are tightly regulated. 
One important attribute of the junctional proteins is their 
phosphorylation status which is finely tuned by the balanced 
action of kinases and phosphatases localized to the junctional 
complex.
A barrier with very special characteristics and functions 
is the BBB, located at the level of brain capillaries. Principal 
cellular components of the BBB are endothelial cells, astro-
cytes and pericytes. The BBB has a barrier function, which 
means that it restricts the transport from blood to the brain of 
potentially toxic or harmful substances. This is achieved by 
a fourfold defence line. Tight junctions form the paracellular 
barrier. Low levels of pinocytosis and transcytosis maintain 
the transcellular barrier. Unwanted peptides and small mol-
ecules are destroyed by the enzymatic barrier. Finally efflux 
pumps such as ABCB1, ABCC family members and ABCG2 
act to remove toxins. The BBB also has a carrier function 
which implies transport of nutrients to the brain and removal 
of metabolites. In this process, SLC transporters play crucial 
role. Due to its strategic location between blood and CNS, the 
BBB plays an important role in the pathogenesis and treat-
ment of a large number of neurological diseases.
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